J Reiffers
About
In The Last Decade
J Reiffers
32 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 64
- Hematology 850
- Public Health, Environmental and Occupational Health 411
- Oncology 268
- Pediatrics, Perinatology and Child Health 178
- Molecular Biology 108
Countries citing papers authored by J Reiffers
This map shows the geographic impact of J Reiffers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Reiffers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Reiffers more than expected).
Fields of papers citing papers by J Reiffers
This network shows the impact of papers produced by J Reiffers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Reiffers. The network helps show where J Reiffers may publish in the future.
Co-authorship network of co-authors of J Reiffers
This figure shows the co-authorship network connecting the top 25 collaborators of J Reiffers. A scholar is included among the top collaborators of J Reiffers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Reiffers. J Reiffers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literature. | 19 |
| 3 | Early infectious complications after bone marrow transplantation requiring medical ICU admission. | 9 |
| 4 | 44 | |
| 5 | High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia. | 5 |
| 6 | 2 | |
| 7 | 56 | |
| 8 | 150 | |
| 9 | 130 | |
| 10 | [Malabsorption syndrome caused by digestive amyloidosis. Uncommon manifestation of light chain myeloma in a 38-year-old woman]. | 1 |
| 11 | 18 | |
| 12 | Treatment of acute myeloid leukemia in elderly patients: the influence of maintenance therapy (BGM 84 protocol). | 16 |
| 13 | 47 | |
| 14 | 15 | |
| 15 | Donor bone marrow treatment with T101 Fab fragment-ricin A-chain immunotoxin prevents graft-versus-host disease. | 13 |
| 16 | Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults. | 8 |
| 17 | 40 | |
| 18 | 12 | |
| 19 | 45 | |
| 20 | [Intestinal decontamination in the neutropenic patient. Apropos of a prospective randomized study]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.